{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:57:11Z","timestamp":1787921831151,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013822","name":"Kurdistan University Of Medical Sciences","doi-asserted-by":"publisher","award":["IR.MUK.REC.1398.315"],"award-info":[{"award-number":["IR.MUK.REC.1398.315"]}],"id":[{"id":"10.13039\/501100013822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10528-024-10754-0","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:03:37Z","timestamp":1711544617000},"page":"1298-1309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model"],"prefix":"10.1007","volume":"63","author":[{"given":"Zhila","family":"Bahramirad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Raman","family":"Moloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Moradzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-9653","authenticated-orcid":false,"given":"Zakaria","family":"Vahabzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"issue":"1","key":"10754_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13105-021-00852-7","volume":"78","author":"A Abdolahi","year":"2022","unstructured":"Abdolahi A, Vahabzadeh Z, Izadpanah E, Moloudi MR (2022) Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway. J Physiol Biochem 78(1):185\u2013197","journal-title":"J Physiol Biochem"},{"issue":"1","key":"10754_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/obr.12765","volume":"20","author":"A Baranova","year":"2019","unstructured":"Baranova A, Maltseva D, Tonevitsky A (2019) Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation. Obes Rev 20(1):108\u2013118","journal-title":"Obes Rev"},{"issue":"2","key":"10754_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MIB.0000000000000687","volume":"22","author":"NJ B\u00e9res","year":"2016","unstructured":"B\u00e9res NJ, Szab\u00f3 D, Kocsis D, Sz\u0171cs D, Kiss Z, M\u00fcller KE, Lendvai G, Kiss A, Arat\u00f3 A, Sziksz E (2016) Role of altered expression of miR-146a, miR-155, and miR-122 in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 22(2):327\u2013335","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10754_CR4","doi-asserted-by":"publisher","first-page":"jcs258322","DOI":"10.1242\/jcs.258322","volume":"135","author":"BB Boumelhem","year":"2022","unstructured":"Boumelhem BB, Pilgrim C, Zwicker VE, Kolanowski JL, Yeo JH, Jolliffe KA, New EJ, Day ML, Assinder SJ, Fraser ST (2022) Intracellular flow cytometric lipid analysis\u2014a multiparametric system to assess distinct lipid classes in live cells. J Cell Sci 135(5):jcs258322","journal-title":"J Cell Sci"},{"issue":"2","key":"10754_CR5","doi-asserted-by":"publisher","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang Q-Y, Mi MT (2016a) Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. Mbio 7(2):e02210-02215","journal-title":"Mbio"},{"issue":"1","key":"10754_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"YM Chen","year":"2016","unstructured":"Chen YM, Liu Y, Zhou RF, Chen XL, Wang C, Tan XY, Wang LJ, Zheng RD, Zhang HW, Ling WH (2016b) Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep 6(1):1\u20139","journal-title":"Sci Rep"},{"issue":"6","key":"10754_CR7","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22569","volume":"48","author":"O Cheung","year":"2008","unstructured":"Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ (2008) Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48(6):1810\u20131820","journal-title":"Hepatology"},{"issue":"3","key":"10754_CR8","first-page":"114","volume":"75","author":"W Cornatzer","year":"1955","unstructured":"Cornatzer W (1955) Lipotropic action of choline in liver disease. J Lancet 75(3):114\u2013117","journal-title":"J Lancet"},{"key":"10754_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.567654","volume":"11","author":"X Dai","year":"2020","unstructured":"Dai X, Hou H, Zhang W, Liu T, Li Y, Wang S, Wang B, Cao H (2020) Microbial metabolites: critical regulators in NAFLD. Front Microbiol 11:567654","journal-title":"Front Microbiol"},{"issue":"20","key":"10754_CR10","doi-asserted-by":"publisher","first-page":"11145","DOI":"10.3390\/ijms222011145","volume":"22","author":"L D\u00edez-Ricote","year":"2021","unstructured":"D\u00edez-Ricote L, Ruiz-Valderrey P, Mic\u00f3 V, Blanco-Rojo R, Tom\u00e9-Carneiro J, D\u00e1valos A, Ordov\u00e1s JM, Daimiel L (2021) Trimethylamine n-oxide (TMAO) modulates the expression of cardiovascular disease-related microRNAs and their targets. Int J Mol Sci 22(20):11145","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10754_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep13729","volume":"5","author":"J Ding","year":"2015","unstructured":"Ding J, Li M, Wan X, Jin X, Chen S, Yu C, Li Y (2015a) Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease. Sci Rep 5(1):1\u201310","journal-title":"Sci Rep"},{"issue":"1","key":"10754_CR12","doi-asserted-by":"publisher","first-page":"13729","DOI":"10.1038\/srep13729","volume":"5","author":"J Ding","year":"2015","unstructured":"Ding J, Li M, Wan X, Jin X, Chen S, Yu C, Li Y (2015b) Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease. Sci Rep 5(1):13729","journal-title":"Sci Rep"},{"issue":"1","key":"10754_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-018-0939-6","volume":"17","author":"L Ding","year":"2018","unstructured":"Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, Zhang T, Wang Y (2018) Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis 17(1):1\u20138","journal-title":"Lipids Health Dis"},{"issue":"12","key":"10754_CR14","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/ijms19123966","volume":"19","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL (2018) miRNA signature in NAFLD: a turning point for a non-invasive diagnosis. Int J Mol Sci 19(12):3966","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10754_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hep4.1501","volume":"4","author":"G Ezaz","year":"2020","unstructured":"Ezaz G, Trivedi HD, Connelly MA, Filozof C, Howard K, Parrish ML, Kim M, Herman MA, Nasser I, Afdhal NH (2020) Differential associations of circulating MicroRNAs with pathogenic factors in NAFLD. Hepatology Communications 4(5):670\u2013680","journal-title":"Hepatology Communications"},{"issue":"10","key":"10754_CR16","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/liv.14963","volume":"41","author":"JL Flores-Guerrero","year":"2021","unstructured":"Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, Bakker SJ, Dullaart RP (2021) Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int 41(10):2371\u20132382","journal-title":"Liver Int"},{"issue":"7","key":"10754_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"2","key":"10754_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12072-013-9468-6","volume":"7","author":"M Ganz","year":"2013","unstructured":"Ganz M, Szabo G (2013) Immune and inflammatory pathways in NASH. Hep Intl 7(2):771\u2013781","journal-title":"Hep Intl"},{"issue":"4","key":"10754_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/jpm10040170","volume":"10","author":"M Gjorgjieva","year":"2020","unstructured":"Gjorgjieva M, Sobolewski C, Ay AS, Abegg D, Correia de Sousa M, Portius D, Berthou F, Fournier M, Maeder C, Rantakari P (2020) Genetic ablation of miR-22 fosters diet-induced obesity and NAFLD development. J Personal Med 10(4):170","journal-title":"J Personal Med"},{"issue":"3","key":"10754_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1083\/jcb.100.3.965","volume":"100","author":"P Greenspan","year":"1985","unstructured":"Greenspan P, Mayer EP, Fowler SD (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100(3):965\u2013973","journal-title":"J Cell Biol"},{"issue":"24","key":"10754_CR21","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13532","volume":"5","author":"PJ Gunn","year":"2017","unstructured":"Gunn PJ, Green CJ, Pramfalk C, Hodson L (2017) In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum. Physiol Rep 5(24):e13532","journal-title":"Physiol Rep"},{"issue":"19","key":"10754_CR22","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","volume":"425","author":"AM Gurtan","year":"2013","unstructured":"Gurtan AM, Sharp PA (2013) The role of miRNAs in regulating gene expression networks. J Mol Biol 425(19):3582\u20133600","journal-title":"J Mol Biol"},{"key":"10754_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8690592","author":"R Huang","year":"2019","unstructured":"Huang R, Duan X, Fan J, Li G, Wang B (2019) Role of noncoding RNA in development of nonalcoholic fatty liver disease. BioMed Res Int. https:\/\/doi.org\/10.1155\/2019\/8690592","journal-title":"BioMed Res Int"},{"issue":"3","key":"10754_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/2211536607666180531093302","volume":"7","author":"K Jampoka","year":"2018","unstructured":"Jampoka K, Muangpaisarn P, Khongnomnan K, Treeprasertsuk S, Tangkijvanich P, Payungporn S (2018) Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD). Microrna 7(3):215\u2013222","journal-title":"Microrna"},{"issue":"4","key":"10754_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.7150\/ijbs.10809","volume":"11","author":"M Li","year":"2015","unstructured":"Li M, Guo K, Vanella L, Taketani S, Adachi Y, Ikehara S (2015) Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice. Int J Biol Sci 11(4):472","journal-title":"Int J Biol Sci"},{"issue":"13","key":"10754_CR26","doi-asserted-by":"publisher","first-page":"17021","DOI":"10.18632\/oncotarget.7740","volume":"7","author":"C Li","year":"2016","unstructured":"Li C, Deng M, Hu J, Li X, Chen L, Ju Y, Hao J, Meng S (2016) Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels. Oncotarget 7(13):17021","journal-title":"Oncotarget"},{"issue":"3","key":"10754_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41374-018-0091-y","volume":"99","author":"Z Li","year":"2019","unstructured":"Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M (2019) Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest 99(3):346\u2013357","journal-title":"Lab Invest"},{"key":"10754_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4634172","author":"Y Liu","year":"2020","unstructured":"Liu Y, Dai M (2020) Trimethylamine N-oxide generated by the gut microbiota is associated with vascular inflammation: new insights into atherosclerosis. Med Inflam. https:\/\/doi.org\/10.1155\/2020\/4634172","journal-title":"Med Inflam"},{"issue":"11","key":"10754_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/1751-2980.12408","volume":"17","author":"XL Liu","year":"2016","unstructured":"Liu XL, Cao HX, Fan JG (2016) MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. J Dig Dis 17(11):708\u2013715","journal-title":"J Dig Dis"},{"issue":"46","key":"10754_CR30","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.3748\/wjg.v23.i46.8140","volume":"23","author":"XL Liu","year":"2017","unstructured":"Liu XL, Cao HX, Wang BC, Xin FZ, Zhang RN, Zhou D, Yang RX, Zhao ZH, Pan Q, Fan JG (2017) miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J Gastroenterol 23(46):8140","journal-title":"World J Gastroenterol"},{"key":"10754_CR31","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-5043","author":"X Liu","year":"2021","unstructured":"Liu X, Shao Y, Tu J, Sun J, Li L, Tao J, Chen J (2021) Trimethylamine-n-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa b signaling. Ann Transl Med. https:\/\/doi.org\/10.21037\/atm-21-5043","journal-title":"Ann Transl Med"},{"issue":"1","key":"10754_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-019-0085-2","volume":"25","author":"JK Long","year":"2019","unstructured":"Long JK, Dai W, Zheng YW, Zhao S-P (2019) miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med 25(1):1\u201313","journal-title":"Mol Med"},{"issue":"5","key":"10754_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","volume":"15","author":"HK Min","year":"2012","unstructured":"Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, Kellum J, Warnick R, Contos MJ, Sanyal AJ (2012) Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 15(5):665\u2013674","journal-title":"Cell Metab"},{"issue":"1","key":"10754_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.advms.2017.06.006","volume":"63","author":"A Mohammadi","year":"2018","unstructured":"Mohammadi A, Vahabzadeh Z, Jamalzadeh S, Khalili T (2018) Trimethylamine-N-oxide, as a risk factor for atherosclerosis, induces stress in J774A. 1 murine macrophages. Adv Med Sci 63(1):57\u201363","journal-title":"Adv Med Sci"},{"issue":"41","key":"10754_CR35","doi-asserted-by":"publisher","first-page":"15079","DOI":"10.3748\/wjg.v20.i41.15079","volume":"20","author":"N Panera","year":"2014","unstructured":"Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A (2014) MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol: WJG 20(41):15079","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"10754_CR36","first-page":"62","volume":"8","author":"R Patell","year":"2014","unstructured":"Patell R, Dosi R, Joshi H, Sheth S, Shah P, Jasdanwala S (2014) Non-alcoholic fatty liver disease (NAFLD) in obesity. J Clin Diagn Res: JCDR 8(1):62","journal-title":"J Clin Diagn Res: JCDR"},{"issue":"4","key":"10754_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","volume":"9","author":"A Purushotham","year":"2009","unstructured":"Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9(4):327\u2013338","journal-title":"Cell Metab"},{"issue":"1","key":"10754_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38262","volume":"6","author":"E Raitoharju","year":"2016","unstructured":"Raitoharju E, Sepp\u00e4l\u00e4 I, Lyytik\u00e4inen LP, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T (2016) Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism\u2014the young finns study. Sci Rep 6(1):1\u201313","journal-title":"Sci Rep"},{"key":"10754_CR39","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.3389\/fmicb.2019.02966","volume":"10","author":"S Rath","year":"2020","unstructured":"Rath S, Rud T, Pieper DH, Vital M (2020) Potential TMA-producing bacteria are ubiquitously found in mammalia. Front Microbiol 10:2966","journal-title":"Front Microbiol"},{"issue":"4","key":"10754_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265455","volume":"17","author":"M Salman","year":"2022","unstructured":"Salman M, Kamel MA, El-Nabi SEH, Ismail AHA, Ullah S, Al-Ghamdi A, Hathout HM, El-Garawani IM (2022) The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis. PLoS ONE 17(4):e0265455","journal-title":"PLoS ONE"},{"issue":"2","key":"10754_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM (2016) Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. J Am Heart Assoc 5(2):e002767","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10754_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1194\/jlr.M051680","volume":"56","author":"DM Shih","year":"2015","unstructured":"Shih DM, Wang Z, Lee R, Meng Y, Che N, Charugundla S, Qi H, Wu J, Pan C, Brown JM (2015) Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis [S]. J Lipid Res 56(1):22\u201337","journal-title":"J Lipid Res"},{"issue":"9","key":"10754_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","volume":"10","author":"G Szabo","year":"2013","unstructured":"Szabo G, Bala S (2013) MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 10(9):542\u2013552","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7341","key":"10754_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung YM (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57\u201363","journal-title":"Nature"},{"issue":"1","key":"10754_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8466","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zalzala M, Xu J, Li Y, Yin L, Zhang Y (2015) A metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism. Nat Commun 6(1):1\u201311","journal-title":"Nat Commun"},{"key":"10754_CR46","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3389\/fphar.2019.01360","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y (2019) Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front Pharmacol 10:1360","journal-title":"Front Pharmacol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10754-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10754-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10754-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T07:40:18Z","timestamp":1743061218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10754-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10754"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10754-0","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial interest and nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}